PACS Insider Stock Sales
PACS Group Insiders Sell Additional Shares Under Pre-Arranged Trading Plans
Anonymous
Key Points
1
Jason Murray Hulse’s 19,617 shares were sold in three separate transactions: 8,771 shares at a weighted-average $45.1608 on Sept. 10, 10,529 shares at $45.2265 on Sept. 11, and 317 shares at $45.0309 on Sept. 14. The sales were made under a Rule 10b5-1 plan adopted May 18, 2026.
2
Mark Hancock’s Rule 10b5-1 trading plan was adopted on March 11, 2026; his Sept. 14-15 sales were reported at five weighted-average prices: $44.5582, $44.9052, $42.0907, $42.8887 and $43.7485.
3
Across the past six months, PACS insiders recorded 54 open-market transactions—54 sales and no purchases. In addition to Hancock and Hulse, President and COO Joshua Jergensen sold 116,335 shares, Chief Legal Officer John Todd Mitchell sold 80,152 shares, and Chief Accounting Officer Michelle Renee Lewis sold 30,000 shares.
4
PACS Group operates primarily in skilled nursing and post-acute healthcare, with services including short- and long-term care, rehabilitation and related care. Its results and outlook are sensitive to Medicare and Medicaid reimbursement, managed-care arrangements, labor costs, staffing conditions and regulatory changes.
Mark Hancock, a director and 10% owner of PACS Group, sold 300,000 shares on September 14-15, 2026 at weighted-average prices between $42.09 and $44.91, totaling roughly $13 million Investing. The sales followed a pre-arranged Rule 10b5-1 trading plan adopted in March 2026. CEO Jason Murray Hulse also sold 19,617 shares across three transactions in mid-September at around $45 per share, leaving him with 54.6 million shares.
Heavy Insider Selling Across PACS Leadership
PACS insiders have executed 54 open-market stock sales over the past six months with zero purchases defenseworld. Beyond Hancock and Hulse, President Joshua Jergensen sold 116,335 shares, Chief Legal Officer John Todd Mitchell sold 80,152 shares, and Chief Accounting Officer Michelle Renee Lewis sold 30,000 shares. The consistent one-way selling reflects executives' confidence in converting holdings to cash rather than reinvesting in the company.
Rule 10b5-1 Plans Lock in Automatic Share Sales
Both Hancock and Hulse's transactions occurred under pre-arranged Rule 10b5-1 trading plans, which allow insiders to schedule stock sales in advance to avoid insider-trading accusations watchlistnews. Hulse adopted his plan on May 18, 2026, while Hancock's was adopted March 11, 2026. These structured plans let executives systematize their exits without worrying about trading windows or regulatory concerns.
PACS Revenue Grows 10% Despite Market Volatility
PACS Group reported first-half 2026 revenue of $2.85 billion, up 10.12% year-over-year Investing. The healthcare company operates skilled nursing facilities and post-acute care centers. Its business depends heavily on Medicare and Medicaid reimbursement rates, managed-care contracts, labor availability, and regulatory compliance—all areas facing pressure in 2026.
Why Insiders Dump Stock at Higher Prices
Stock sales by company leaders often signal they view current prices as attractive exits. Hancock's sales at $42-$45 per share, combined with his director status and 10% ownership stake, suggest he is taking profits rather than betting against the company. The September 2026 timing—during peak healthcare reimbursement season—may have made these price points attractive selling opportunities for the PACS leadership team.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
14
Articles
38
Reach
52
A
AnonymousAuthor
